OHSU board unanimously passes resolution to become a national leader in developing new techniques to advance scientific understanding of human disease while over time reducing the number of nonhuman primates needed for research.

OHSU board unanimously passes resolution to become a national leader in developing new techniques to advance scientific understanding of human disease while over time reducing the number of nonhuman primates needed for research

Reason magazine revisits debate over the role of decriminalization in driving illicit drug overdose rates in Oregon, citing a news article from 2024 quoting Todd Korthuis, M.D.

Becker’s Behavioral Health reports that the American Hospital Association released new resources compiled in part by OHSU to help hospital and health systems improve care transitions and long-term engagement in treatment for patients with opioid use disorder and stimulant use disorder.

Hillsboro Medical Center, affiliated with OHSU since 2016, will close its 21-bed geriatric psychiatry unit on Sept. 4.

Northwest Construction News reports that Skanska has completed construction of OHSU’s Vista Pavilion, “delivering one of the most technically demanding healthcare construction projects Oregon has ever seen.”

Everyday Health reports that acromegaly, a condition caused by excess levels of growth hormone, can cause multiple symptoms including problems with vision. Maria Fleseriu, M.D., says, “Vision impairment is usually related to the size and location of the pituitary adenoma.”

In a Healio Gastroenterology story about developing noninvasive methods of colorectal cancer screening, David Lieberman, M.D., says, “Blood-based tests — which can detect circulating free DNA associated with colon cancer — are potentially the holy grail of colon cancer screening.”

KXL-Radio publishes an Oregon Radio News Network story about a state-funded training program to fill gaps in the healthcare workforce, Claire Irvan says, “It was a great way to say, ‘here is an opportunity for low-wage earners to embark on a career path.”

a team at OHSU became the first in Oregon to implant a new type of radioactive tile roughly the size of a postage stamp to improve the outcome for patients with brain tumors. Stephen Bowden, M.D., says, “GammaTile gives us the option to do that radiation safely and at the same time as the surgery:”